JYNNEOS vaccination induced short-lived neutralizing antibody responses to monkeypox virus in naive individuals
Phipps, K.; Yates, J. L.; Machowski, J.; Bialosuknia, S.; Hunt, D.; Dupuis, A. L.; Payne, A.; Lee, W.; McDonough, K.
Show abstract
Current studies of the JYNNEOS-induced neutralizing antibody response to monkeypox virus (MPXV) are limited by either short-term durability data, quantification in an endemic population, or lack of an infectious MPXV neutralization assay. We used plaque reduction neutralization test (PRNT) with authentic MPXV and vaccinia viruse (VACV) to assess antibody responses over twelve months of eight donors vaccinated with two doses of JYNNEOS. One donor previously received the ACAM2000 vaccine; seven donors were smallpox-vaccine naive. The IgG response of the donors to VACV (L1R, B5R, and A33R) and MPXV (E8L, H3L, A35R) antigens and PRNT titers to both viruses peaked at eight weeks post-vaccination and waned thereafter in naive donors. MPXV PRNT titers were especially low; no naive donors produced a detectable PRNT90 titer. Our results suggest the MPXV humoral response produced by JYNNEOS is limited in naive donors and invites further investigation into current mpox vaccination strategies and correlates of protection.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Post-vaccination SARS-COV-2 among healthcare workers in New Jersey: a genomic epidemiological study 94%
- Functional and quantitative evaluation of BNT162b2 SARS-CoV-2 vaccine-induced immunity 93%
- SARS-CoV-2 Convalescent Sera Binding and Neutralizing Antibody Concentrations Compared with COVID-19 Vaccine Efficacy Estimates Against Symptomatic Infection 93%
Similar papers in this journal
- Novel Hendra virus variant detected by sentinel surveillance of Australian horses. 94%
- Respiratory shedding of infectious SARS-CoV-2 Omicron XBB.1.41.1 lineage with increased evolutionary rate among captive white-tailed deer 94%
- Susceptibility of raccoon dogs for experimental SARS-CoV-2 infection 93%
Similar papers in this journal
- A Newcastle disease virus (NDV) expressing membrane-anchored spike as a cost-effective inactivated SARS-CoV-2 vaccine 96%
- Intranasal immunization with a vaccinia virus vaccine vector expressing pre-fusion stabilized SARS-CoV-2 spike fully protected mice against lethal challenge with the heavily mutated mouse-adapted SARS2-N501YMA30 strain of SARS-CoV-2 95%
- Immunogenicity and Efficacy of TNX-1800, A Live Virus Recombinant Poxvirus Vaccine Candidate, Against SARS-CoV-2 Challenge in Nonhuman Primates 95%
Similar papers in this journal
- Vaccine-induced, high magnitude HIV Env-specific antibodies with Fc-mediated effector functions are insufficient to protect infant rhesus macaques against oral SHIV infection 95%
- Impact of prior infection on SARS-CoV-2 antibody responses in vaccinated long-term care facility staff 95%
- Broadly Reactive H2 Hemagglutinin Vaccines Elicit Cross-Reactive Antibodies in Ferrets Pre-Immune to Seasonal Influenza A Viruses 94%
Similar papers in this journal
- A bivalent Adenovirus-Vectored Vaccine induces a measurable humoral response, but does not protect cynomolgus macaques against a lethal challenge with Sudan virus 97%
- Slow waning of antibodies following a third dose of BNT162b2 in adults who had previously received two doses of inactivated vaccine 94%
- SARS-CoV-2 seroassay optimization and performance in a population with high background reactivity in Mali 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.